Eosinophilic Bronchiolitis Successfully Treated with Benralizumab

Overview

Journal BMJ Case Rep

Specialty General Medicine

Date 2021 Oct 20

PMID 34667050

Citations 1

Authors

Keishi Sugino

Hirotaka Ono

Akira Hebisawa

Eiyasu Tsuboi

Affiliations

Soon will be listed here.

Abstract

A 53-year-old non-smoking Japanese woman was admitted to our hospital with a 20-year history of wet cough and dyspnoea on exertion. Bronchial asthma (BA) had been diagnosed 20 years earlier. Although she has been treated with high-dose inhaled corticosteroid, she had experienced frequent exacerbation of BA, and short-term oral corticosteroid bursts were occasionally administered. High-resolution CT of the chest revealed diffuse centrilobular nodules with bronchial wall thickening and patchy ground-glass opacities in both lungs. Lung biopsy specimens showed widespread cellular bronchiolitis with follicle formations in the membranous and respiratory bronchioles, accompanied by marked infiltration of plasma cells and eosinophils. In addition, immunohistochemical immunoglobulin G4 (IgG4) staining revealed many IgG4-positive plasma cells, and the ratio of IgG4-positive cells to IgG-positive cells exceeded 40%. The final diagnosis was eosinophilic bronchiolitis with marked IgG4-positive plasma cell infiltration in association with BA. With benralizumab therapy, her clinical condition dramatically improved.

Citing Articles

Development of eosinophilic pneumonia from eosinophilic bronchiolitis without asthma: A case report.

Mikami E, Atsumi K, Iso H, Suzuki T, Matsuki S, Hisakane K Respir Med Case Rep. 2023; 45:101901.

PMID: 37577123 PMC: 10413186. DOI: 10.1016/j.rmcr.2023.101901.

References

Punnonen J, Aversa G, Cocks B, McKenzie A, Menon S, Zurawski G . Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A. 1993; 90(8):3730-4. PMC: 46375. DOI: 10.1073/pnas.90.8.3730. View

Takayanagi N, Kanazawa M, Kawabata Y, Colby T . Chronic bronchiolitis with associated eosinophilic lung disease (eosinophilic bronchiolitis). Respiration. 2001; 68(3):319-22. DOI: 10.1159/000050518. View

Zen Y, Nakanuma Y . IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010; 34(12):1812-9. DOI: 10.1097/PAS.0b013e3181f7266b. View

MASI A, Hunder G, Lie J, Michel B, Bloch D, Arend W . The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990; 33(8):1094-100. DOI: 10.1002/art.1780330806. View

Takeshita Y, Nobuyama S, Kanetsuna Y, Tanaka A, Adachi M, Sato T . Eosinophilic bronchiolitis successfully treated with mepolizumab. J Allergy Clin Immunol Pract. 2019; 8(3):1159-1161.e1. DOI: 10.1016/j.jaip.2019.10.013. View

Wang X, Wan J, Zhao L, Da J, Cao B, Zhai Z . IgG4-related disease with tracheobronchial miliary nodules and asthma: a case report and review of the literature. BMC Pulm Med. 2019; 19(1):191. PMC: 6822466. DOI: 10.1186/s12890-019-0957-9. View

Jeannin P, Lecoanet S, Delneste Y, Gauchat J, Bonnefoy J . IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol. 1998; 160(7):3555-61. View

Bleecker E, FitzGerald J, Chanez P, Papi A, Weinstein S, Barker P . Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. Lancet. 2016; 388(10056):2115-2127. DOI: 10.1016/S0140-6736(16)31324-1. View

Kamisawa T, Takuma K, Egawa N, Tsuruta K, Sasaki T . Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol. 2010; 7(7):401-9. DOI: 10.1038/nrgastro.2010.81. View

10.

Cordier J, Cottin V, Khouatra C, Revel D, Proust C, Freymond N . Hypereosinophilic obliterative bronchiolitis: a distinct, unrecognised syndrome. Eur Respir J. 2012; 41(5):1126-34. DOI: 10.1183/09031936.00099812. View

11.

Nair P, Wenzel S, Rabe K, Bourdin A, Lugogo N, Kuna P . Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma. N Engl J Med. 2017; 376(25):2448-2458. DOI: 10.1056/NEJMoa1703501. View

12.

Flament T, Marchand-Adam S, Gatault P, Dupin C, Diot P, Guilleminault L . What are the characteristics of asthma patients with elevated serum IgG4 levels?. Respir Med. 2016; 112:39-44. DOI: 10.1016/j.rmed.2016.01.014. View

13.

Takeuchi M, Sato Y, Ohno K, Tanaka S, Takata K, Gion Y . T helper 2 and regulatory T-cell cytokine production by mast cells: a key factor in the pathogenesis of IgG4-related disease. Mod Pathol. 2014; 27(8):1126-36. DOI: 10.1038/modpathol.2013.236. View